Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6-Reference-Cited by-同舟云学术

Systematic review: cost-effectiveness of direct-acting antivirals for treatment of hepatitis C genotypes 2-6

Published:2017-08-24 Issue:8 Volume:46 Page:711-721
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

He T.¹,Lopez-Olivo M. A.²,Hur C.³⁴⁵,Chhatwal J.³⁴⁵^ORCID

Affiliation:

1. Department of Internal Medicine; Peking Union Medical College Hospital; Peking Union Medical College and Chinese Academy of Medical Sciences; Beijing China

2. Department of General Internal Medicine; The University of Texas, MD Anderson Cancer Center; Houston TX USA

3. Institute for Technology Assessment; Massachusetts General Hospital; Boston MA USA

4. Harvard Medical School; Boston MA USA

5. Liver Center and Gastrointestinal Division; Massachusetts General Hospital; Boston MA USA

Funder

Gilead Sciences

Merck

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14271/fullpdf

Reference58 articles.

1. Hepatitis C fact sheet http://www.who.int/mediacentre/factsheets/fs164/en

2. Clinical practice. Chronic hepatitis C infection;Rosen;N Engl J Med,2011

3. Global distribution and prevalence of hepatitis C virus genotypes;Messina;Hepatology,2015

4. Evolving epidemiology of hepatitis C virus;Lavanchy;Clin Microbiol Infect,2011

5. Hepatitis C disease burden in the United States in the era of oral direct-acting antivirals;Chhatwal;Hepatology (Baltimore, MD),2016

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is it time for China to prioritize pan-genotypic regimens for treating patients with hepatitis C?;Cost Effectiveness and Resource Allocation;2024-02-06

2. Trends in Hepatitis C Virus and HIV Care Outcomes Among People With HIV in Georgia, United States, 2014-2019;Public Health Reports;2023-11-04

3. Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California;The American Journal of Managed Care;2023-10-20

4. The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada;PLOS ONE;2023-08-08

5. World Hepatitis Day 2023: Are we close to the target?;Indian Journal of Medical Research;2023